Merck to acquire biotech company Prometheus Biosciences for $10.8bn
Merck has agreed to acquire Prometheus Biosciences, a Nasdaq-listed clinical-stage biotechnology company, in an all-cash deal worth around $10.8 billion, in a move to bolster ... Read More
Eris Lifesciences strikes deal for Dr. Reddy’s cosmetic dermatology brands
Eris Lifesciences has announced the acquisition of nine cosmetic dermatology brands in the Indian market from Dr. Reddy's Laboratories for INR 275 crores in cash. ... Read More
Pfizer to acquire cancer drugmaker Seagen for $43bn in cash
American pharmaceutical and biotechnology company Pfizer has agreed to acquire cancer drugmaker Seagen (formerly Seattle Genetics) for $229 per share or $43 billion in cash, ... Read More
Sesen Bio gets shareholders’ approval for merger with Carisma Therapeutics
Nasdaq-listed Sesen Bio said that its stockholders have approved the previously announced merger deal with Carisma Therapeutics aimed at creating a clinical-stage biotechnology company for ... Read More
Dr. Reddy’s Laboratories to acquire Mayne Pharma’s US retail generics portfolio
Dr. Reddy's Laboratories has agreed to acquire the US generic prescription product portfolio of Mayne Pharma Group, an Australian pharma company, in a deal worth ... Read More
AstraZeneca wraps up $1.8bn acquisition of CinCor Pharma
AstraZeneca has closed the previously announced $1.8 billion acquisition of US biopharmaceutical company CinCor Pharma. Under the terms of the agreement, AstraZeneca acquired all outstanding ... Read More
Clinical-stage Redx Pharma, Jounce Therapeutics sign $425m merger deal
Redx Pharma, a UK-based clinical-stage biotechnology company, and Jounce Therapeutics, a Nasdaq-listed clinical-stage immunotherapy company, have agreed to merge in an all-stock deal that values ... Read More
Sol-Gel acquires Gorlin syndrome drug candidate Patidegib from PellePharm
Sol-Gel Technologies, an Israel-based dermatology company, has acquired patidegib, a Gorlin syndrome drug candidate in phase 3 development, from US-based biotechnology company PellePharm, in a ... Read More
Sun Pharma to acquire Concert Pharmaceuticals to bolster dermatology franchise
India-based Sun Pharmaceutical Industries (Sun Pharma) will acquire US-based Concert Pharmaceuticals for equity consideration of $576 million to strengthen its global dermatology franchise. Concert Pharmaceuticals ... Read More
AstraZeneca closes acquisition of cell therapy company Neogene Therapeutics
Pharma giant AstraZeneca has closed the previously announced acquisition of Neogene Therapeutics, a US-based clinical-stage biotechnology company. Neogene Therapeutics is engaged in the discovery, development, ... Read More